Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence

Evidence from recent sham-controlled trials supports the use of endovascular renal denervation (RDN) to lower blood pressure in general as well as in treatment-resistant hypertension. According to recent studies, the effects of RDN are long lasting. Newer technologies using multipolar radiofrequency...

Descripción completa

Detalles Bibliográficos
Autor principal: Fengler, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381663/
https://www.ncbi.nlm.nih.gov/pubmed/35943714
http://dx.doi.org/10.1007/s40119-022-00275-5
_version_ 1784769124781522944
author Fengler, Karl
author_facet Fengler, Karl
author_sort Fengler, Karl
collection PubMed
description Evidence from recent sham-controlled trials supports the use of endovascular renal denervation (RDN) to lower blood pressure in general as well as in treatment-resistant hypertension. According to recent studies, the effects of RDN are long lasting. Newer technologies using multipolar radiofrequency catheters and an additional ablation of the renal side branches as well as ultrasound with improved circumferential tissue penetration have made these advances possible. This has initiated a change of the perspective on RDN in clinical guidelines and has thereby set a cornerstone for a broader clinical application of RDN in the future.
format Online
Article
Text
id pubmed-9381663
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-93816632022-08-18 Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence Fengler, Karl Cardiol Ther Review Evidence from recent sham-controlled trials supports the use of endovascular renal denervation (RDN) to lower blood pressure in general as well as in treatment-resistant hypertension. According to recent studies, the effects of RDN are long lasting. Newer technologies using multipolar radiofrequency catheters and an additional ablation of the renal side branches as well as ultrasound with improved circumferential tissue penetration have made these advances possible. This has initiated a change of the perspective on RDN in clinical guidelines and has thereby set a cornerstone for a broader clinical application of RDN in the future. Springer Healthcare 2022-08-09 2022-09 /pmc/articles/PMC9381663/ /pubmed/35943714 http://dx.doi.org/10.1007/s40119-022-00275-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Fengler, Karl
Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
title Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
title_full Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
title_fullStr Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
title_full_unstemmed Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
title_short Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
title_sort renal denervation for resistant hypertension: a concise update on treatment options and the latest clinical evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381663/
https://www.ncbi.nlm.nih.gov/pubmed/35943714
http://dx.doi.org/10.1007/s40119-022-00275-5
work_keys_str_mv AT fenglerkarl renaldenervationforresistanthypertensionaconciseupdateontreatmentoptionsandthelatestclinicalevidence

Ejemplares similares